302 related articles for article (PubMed ID: 23247264)
1. Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers.
Liu Y; Kong M; Feng C; Yang KK; Li Y; Su J; Cheng XJ; Park HJ; Chen XG
Colloids Surf B Biointerfaces; 2013 Mar; 103():345-53. PubMed ID: 23247264
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of mucoadhesion and permeation enhancement of polymeric amphiphilic nanoparticles.
Liu Y; Di Zang H; Kong M; Ma FK; Dang QF; Cheng XJ; Ji QX; Chen XG
Carbohydr Polym; 2012 Jun; 89(2):453-60. PubMed ID: 24750743
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of oleoyl-carboxymethy-chitosan (OCMCS) nanoparticles as oral protein carriers.
Liu Y; Cheng XJ; Dang QF; Ma FK; Chen XG; Park HJ; Kim BK
J Mater Sci Mater Med; 2012 Feb; 23(2):375-84. PubMed ID: 22139537
[TBL] [Abstract][Full Text] [Related]
4. Polymeric nanoparticles based on chitooligosaccharide as drug carriers for co-delivery of all-trans-retinoic acid and paclitaxel.
Zhang J; Han J; Zhang X; Jiang J; Xu M; Zhang D; Han J
Carbohydr Polym; 2015 Sep; 129():25-34. PubMed ID: 26050884
[TBL] [Abstract][Full Text] [Related]
5. Self-assembled nanoparticles based on amphiphilic chitosan derivative and hyaluronic acid for gene delivery.
Liu Y; Kong M; Cheng XJ; Wang QQ; Jiang LM; Chen XG
Carbohydr Polym; 2013 Apr; 94(1):309-16. PubMed ID: 23544543
[TBL] [Abstract][Full Text] [Related]
6. Glycyrrhizin-modified O-carboxymethyl chitosan nanoparticles as drug vehicles targeting hepatocellular carcinoma.
Shi L; Tang C; Yin C
Biomaterials; 2012 Oct; 33(30):7594-604. PubMed ID: 22796165
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery?
Martien R; Loretz B; Thaler M; Majzoob S; Bernkop-Schnürch A
J Biomed Mater Res A; 2007 Jul; 82(1):1-9. PubMed ID: 17265441
[TBL] [Abstract][Full Text] [Related]
9. Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.
Yeh MK; Cheng KM; Hu CS; Huang YC; Young JJ
Acta Biomater; 2011 Oct; 7(10):3804-12. PubMed ID: 21742066
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Zhang J; Chen XG; Li YY; Liu CS
Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
[TBL] [Abstract][Full Text] [Related]
11. Preparation of itraconazole-loaded liposomes coated by carboxymethyl chitosan and its pharmacokinetics and tissue distribution.
Wang J; Huang G
Drug Deliv; 2011 Nov; 18(8):631-8. PubMed ID: 22111976
[TBL] [Abstract][Full Text] [Related]
12. Curcumin-loaded N,O-carboxymethyl chitosan nanoparticles for cancer drug delivery.
Anitha A; Maya S; Deepa N; Chennazhi KP; Nair SV; Jayakumar R
J Biomater Sci Polym Ed; 2012; 23(11):1381-400. PubMed ID: 21722423
[TBL] [Abstract][Full Text] [Related]
13. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
[TBL] [Abstract][Full Text] [Related]
14. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles.
Nam HY; Kwon SM; Chung H; Lee SY; Kwon SH; Jeon H; Kim Y; Park JH; Kim J; Her S; Oh YK; Kwon IC; Kim K; Jeong SY
J Control Release; 2009 May; 135(3):259-67. PubMed ID: 19331853
[TBL] [Abstract][Full Text] [Related]
15. Uptake of oleoyl-chitosan nanoparticles by A549 cells.
Zhang J; Chen XG; Peng WB; Liu CS
Nanomedicine; 2008 Sep; 4(3):208-14. PubMed ID: 18508414
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.
Slütter B; Plapied L; Fievez V; Sande MA; des Rieux A; Schneider YJ; Van Riet E; Jiskoot W; Préat V
J Control Release; 2009 Sep; 138(2):113-21. PubMed ID: 19445980
[TBL] [Abstract][Full Text] [Related]
17. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Yin L; Ding J; He C; Cui L; Tang C; Yin C
Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C
Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
Mandal BB; Kundu SC
Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
[TBL] [Abstract][Full Text] [Related]
20. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs.
Win KY; Feng SS
Biomaterials; 2005 May; 26(15):2713-22. PubMed ID: 15585275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
